Proto‐Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer
Open Access
- 31 July 2025
- journal article
- Published by Wiley in Cancer Medicine
- Vol. 14 (15) , e71114
Abstract
Background: Mutational landscape is prognostic in colorectal cancer (CRC). Rat sarcoma ( RAS ) oncogenes, such as KRAS and NRAS , with driver mutations, portend poor survival outcomes, whereas pathologic mutations in HRAS are extremely rare, and their prognostic value remains uncertain. Methods: This retrospective study analyzed the Oncology Research Information Exchange Network (ORIEN) alliance tumor RNA‐Seq data in Stages II and III CRC to investigate the association between RAS gene expression and survival outcomes. Results: High transcript levels of HRAS were associated with superior overall survival (OS). The high HRAS ‐associated OS benefit was most pronounced in patients with right‐sided primary expressing low KRAS transcript levels in the absence of pathologic KRAS mutations. Conclusions: Contrary to the notion that RAS family genes are proto‐oncogenic, this study demonstrates that high HRAS transcript levels are associated with superior OS in Stages II and III CRC. The potential of HRAS as a prognostic biomarker should be explored further.Keywords
This publication has 16 references indexed in Scilit:
- Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growthNature Cell Biology, 2023
- Clinical and Functional Characterization of AtypicalKRAS/NRASMutations in Metastatic Colorectal CancerClinical Cancer Research, 2021
- RAS-targeted therapies: is the undruggable drugged?Nature Reviews Drug Discovery, 2020
- Precision Therapy in RAS Mutant Colorectal CancerGastroenterology, 2020
- Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patientsNature Communications, 2019
- CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerNew England Journal of Medicine, 2016
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- A Comprehensive Survey of Ras Mutations in CancerCancer Research, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colonNature Genetics, 2008